PEER-REVIEWED ARTICLES
2023
Ravn-Boess N, Roy N, Hattori T, Bready D, Donaldson H, Lawson C, Lapierre C, Korman A, Rodrick T, Liu E, Frenster JD, Stephan G, Wilcox J, Corrado AD, Cai J, Ronnen R, Wang S, Haddock S, Sabio Ortiz J, Mishkit O, Khodadadi-Jamayran A, Tsirigos A, Fenyö D, Zagzag D, Drube J, Hoffmann C, Perna F, Jones DR, Possemato R, Koide A, Koide S, Park CY, Placantonakis DG. The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability. Cell Reports 2023 Nov 7;42(11):113374. doi: 10.1016/j.celrep.2023.113374.
Gabriele Stephan, Hediye Erdjument-Bromage, Wenke Liu, Joshua D. Frenster, Niklas Ravn-Boess, Devin Bready, Julia Cai, David Fenyo, Thomas Neubert, Dimitris G. Placantonakis. Modulation of GPR133 (ADGRD1) Signaling by its Intracellular Interaction Partner Extended Synaptotagmin 1 (ESYT1). bioRxiv 2023.02.09.527921 (in revision).
Joshua D. Frenster, Hediye Erdjument-Bromage, Gabriele Stephan, Niklas Ravn-Boess, Shuai Wang, Wenke Liu, Devin Bready, Jordan Wilcox, Bjoern Kieslich, Manuel Jankovic, Caroline Wilde, Susanne Horn, Norbert Sträter, Ines Liebscher, Torsten Schöneberg, David Fenyo, Thomas A. Neubert, Dimitris G. Placantonakis. PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma. Cell Reports 2023 42(7):112679. doi: 10.1016/j.celrep.2023.112679.
2022
Francesco Boccalatte, Roberto Mina, Andrea Aroldi, Sarah Leone, Carter M Suryadevara, Dimitris G Placantonakis, Benedetto Bruno. Advances and hurdles of CAR T cell immune therapy in solid tumors. Cancers (Basel) 2022 Oct 18;14(20):5108.doi: 10.3390/cancers14205108.
Sabastian Hajtovic, James Sun, Jasjit S. Multani, Linda Herrmann, Hannah Britton, Jose Gautreaux, Lea Tortolero, Gillian Harrison, John G. Golfinos, Timothy M. Shepherd, Omar Tanweer, & Dimitris G. Placantonakis. Surgical cytoreduction of deep-seated high-grade glioma through tubular retractors. Journal of Neurosurgery 2022. DOI: https://doi.org/10.3171/2022.9.JNS22842.
Gabriele Stephan, Joshua D. Frenster, Ines Liebscher, & Dimitris G. Placantonakis. Activation of the adhesion G protein-coupled receptor GPR133 (ADGRD1) by antibodies targeting its N-terminus. Journal of Biological Chemistry 2022 Apr 18; 298(6):101949. doi: 10.1016/j.jbc.2022.101949.1.
Jakob Mitgau, Julius Franke, Camilla Schinner, Gabriele Stephan, Sandra Berndt, Dimitris G. Placantonakis, Hermann Kalwa, Volker Spindler, Caroline Wilde & Ines Liebscher. The N terminus of adhesion G protein-coupled receptor GPR126/ADGRG6 as allosteric force integrator. Front Cell Dev Biol. 2022 Jun 23;10:873278. doi: 10.3389/fcell.2022.873278.
Liu Q, Chen G, Moore J, Guix I, Placantonakis D, Barcellos-Hoff MH. Exploiting Canonical TGFβ Signaling in Cancer Treatment. Molecular Cancer Therapeutics 2022 Jan; 21(1):16-24. doi: 10.1158/1535-7163.MCT-20-0891.
2021
Joshua D. Frenster, Gabriele Stephan, Niklas Ravn-Boess, Devin Bready, Jordan Wilcox, Bjoern Kieslich, Caroline Wilde, Norbert Sträter, Giselle Wiggin, Ines Liebscher, Torsten Schöneberg, & Dimitris G. Placantonakis. Functional impact of intramolecular cleavage and dissociation of adhesion G protein-coupled receptor GPR133 (ADGRD1) on canonical signaling. Journal of Biological Chemistry 2021 Jan-Jun;296:100798. doi: 10.1016/j.jbc.2021.100798. Epub 2021 May 20.
Jia-Ray Yu, Gary LeRoy, Devin Bready, Joshua D. Frenster, Ricardo Saldana-Meyer, Ying Jin, Nicolas Descostes, James M. Stafford, Dimitris G. Placantonakis, & Danny Reinberg. The H3K36me2 writer-reader dependency in H3K27M-DIPG. Science Advances 2021 Jul 14;7(29):eabg7444. doi: 10.1126/sciadv.abg7444.
Matthias A. Karajannis, Audrey Maguen, Erin Dunbar, Scott R. Plotkin, Ekrem Malokou, Qingwen Xu, Anna Yaffe, Shiyang Wang, J. Thomas Roland, Chandranath Sen, Dimitris G. Placantonakis, John G. Golfinos, Jeffrey C. Allen, Nicholas A, Vitanza, Luis A. Chiriboga, Robert Schneider, Jingjing Deng, Thomas A. Neubert, Judith D. Goldberg, David Zagzag, Filippo G. Giancotti, & Jaishri O. Blakeley. Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma. Mol Cancer Ther 2021 Jun 17;. doi: 10.1158/1535-7163.MCT-21-0143. [Epub ahead of print]
Huang C, Chen L, Savage SR, Eguez RV, Dou Y, Li Y, da Veiga Leprevost F, Jaehnig EJ, Lei JT, Wen B, Schnaubelt M, Krug K, Song X, Cieślik M, Chang HY, Wyczalkowski MA, Li K, Colaprico A, Li QK, Clark DJ, Hu Y, Cao L, Pan J, Wang Y, Cho KC, Shi Z, Liao Y, Jiang W, Anurag M, Ji J, Yoo S, Zhou DC, Liang WW, Wendl M, Vats P, Carr SA, Mani DR, Zhang Z, Qian J, Chen XS, Pico AR, Wang P, Chinnaiyan AM, Ketchum KA, Kinsinger CR, Robles AI, An E, Hiltke T, Mesri M, Thiagarajan M, Weaver AM, Sikora AG, Lubiński J, Wierzbicka M, Wiznerowicz M, Satpathy S, Gillette MA, Miles G, Ellis MJ, Omenn GS, Rodriguez H, Boja ES, Dhanasekaran SM, Ding L, Nesvizhskii AI, El-Naggar AK, Chan DW, Zhang H, Zhang B; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell 2021 Mar 8;39(3):361-379.e16. doi: 10.1016/j.ccell.2020.12.007.
Wang LB, Karpova A, Gritsenko MA, Kyle JE, Cao S, Li Y, Rykunov D, Colaprico A, Rothstein JH, Hong R, Stathias V, Cornwell M, Petralia F, Wu Y, Reva B, Krug K, Pugliese P, Kawaler E, Olsen LK, Liang WW, Song X, Dou Y, Wendl MC, Caravan W, Liu W, Cui Zhou D, Ji J, Tsai CF, Petyuk VA, Moon J, Ma W, Chu RK, Weitz KK, Moore RJ, Monroe ME, Zhao R, Yang X, Yoo S, Krek A, Demopoulos A, Zhu H, Wyczalkowski MA, McMichael JF, Henderson BL, Lindgren CM, Boekweg H, Lu S, Baral J, Yao L, Stratton KG, Bramer LM, Zink E, Couvillion SP, Bloodsworth KJ, Satpathy S, Sieh W, Boca SM, Schürer S, Chen F, Wiznerowicz M, Ketchum KA, Boja ES, Kinsinger CR, Robles AI, Hiltke T, Thiagarajan M, Nesvizhskii AI, Zhang B, Mani DR, Ceccarelli M, Chen XS, Cottingham SL, Li QK, Kim AH, Fenyö D, Ruggles KV, Rodriguez H, Mesri M, Payne SH, Resnick AC, Wang P, Smith RD, Iavarone A, Chheda MG, Barnholtz-Sloan JS, Rodland KD, Liu T, Ding L; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell 2021 Apr 12;39(4):509-528.e20. doi: 10.1016/j.ccell.2021.01.006.
Gabriele Stephan, Niklas Ravn-Boess, & Dimitris G. Placantonakis. Adhesion GPCRs in glioblastoma. Neuro-Oncology Advances 2021 Mar 23;3(1):vdab046. doi: 10.1093/noajnl/vdab046.
2020
Joshua D. Frenster, Michael Kader, Scott Kamen, James Sun, Luis Chiriboga, Jonathan Serrano, Devin Bready, Danielle Golub, Niklas Ravn-Boess, Gabriele Stephan, Andrew S. Chi, Sylvia C. Kurz, Rajan Jain, Christopher Y. Park, David Fenyo, Ines Liebscher, Torsten Schöneberg, Giselle Wiggin, Robert Newman, Matt Barnes, John K. Dickson, Douglas J. MacNeil, Xinyan Huang, Nadim Shohdy, Matija Snuderl, David Zagzag, & Dimitris G. Placantonakis. Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypes. Neuro-Oncology Advances 2020; 2(1):vdaa053. https://doi.org/10.1093/noajnl/vdaa053.
Joshua D. Frenster, Shivang Desai, & Dimitris G. Placantonakis. In vitro evidence for glioblastoma cell death in temperatures found in the penumbra of laser-ablated tumors. International Journal of Hyperthermia 2020; 37(2):20-26. DOI: 10.1080/02656736.2020.1774082.
Xin Cui, Chao Ma, Varshini Vasudevaraja, Jonathan Serrano, Jie Tong, Yansong Peng, Michael Delorenzo, Guomiao Shen, Joshua Frenster, Renee-Tyler Tan Morales, Weiyi Qian, Aristotelis Tsirigos, Andrew S Chi, Rajan Jain, Sylvia C Kurz, Erik P Sulman, Dimitris G Placantonakis, Matija Snuderl, & Weiqiang Chen. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy. Elife 2020 Sep 10;9. doi:10.7554/eLife.52253.
Timothy F. Cloughesy, Kevin Petrecca, Tobias Walbert, Nicholas Butowski, Michael Salacz, James Perry, Denise Damek, Daniela Bota, Chetan Bettegowda, Jay-Jiguang Zhu, Fabio Iwamoto, Dimitris Placantonakis, Lyndon Kim, Brad Elder, George Kaptain, David Cachia, Yaron Moshel, Steven Brem, David Piccioni, Joseph Landolfi, Clark C. Chen, Harry Gruber, Aliz Rao, Daniel Hogan, William Accomando, Derek Ostertag, Tiffany T. Montellano, Thian Kheoh, Fairooz Kabbinavar, & Michael A. Vogelbaum. Effect of vocimagene amiretrorepvec in combination with flucytosine vs standard of care on survival flowing tumor resection in patients with recurrent high-grade glioma. JAMA Oncology 2020 Dec 1;6(12):1939-1946. doi:10.1001/jamaoncol.2020.3161.
2019
Ramona Bledea, Varshini Vasudevaraja, Seema Patel, James Stafford, Jonathan Serrano, Gianna Esposito, Lilian Tredwin, Nina Goodman, Andreas Kloetgen, John Golfinos, David Zagzag, Britta Weigelt, A. John Iafrate, Erik Sulman, Andrew Chi, Dogan Snjezana, Jorge Reis-Filho, Sarah Chiang, Dimitris Placantonakis, Aristotelis Tsirigos, & Matija Snuderl. Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers. Scientific Reports 2019; 9(1):16830. doi: 10.1038/s41598-019-53262-7.
Chih-Chin Wu, Rajan Jain, Lucidio Neto, Seema Patel, Laila M. Poisson, Jonathan Serrano, Victor Ng, Sohil H. Patel, Dimitris G. Placantonakis, David Zagzag, John Golfinos, Andrew S Chi, & Matija Snuderl. MR Imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas. Neuroradiology 2019; 61(9):1023-1031. doi: 10.1007/s00234-019-02219-8.
Danielle Golub, Nishanth Iyengar, Siddhant Dogra, Taylor Wong, Devin Bready, Karen Tang, Aram Sandaldjian Modrek, & Dimitris G. Placantonakis. Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics. Frontiers in Oncology 2019; 9:417. doi: 10.3389/fonc.2019.00417.
Hui Chen, Cheddhi Thomas, Felipe Andres Munoz, Sanda Alexandrescu, Craig M. Horbinski, Adriana Olar, Declan McGuone, Sandra Camelo-Piragua, Lu Wang, Elena Pentsova, Joanna Phillips, Ken Aldape, A. John Iafrate, Andrew Chi, David Zagzag, John G. Golfinos, Dimitris G. Placantonakis, Marc Rosenblum, Pamela Ohman-Strickland, Meera Hameed, & Matija Snuderl. Polysomy of 1p19q is associated with poor outcome in 1p19q co-deleted oligodendroglial tumors. Neurooncology 2019; pii: noz098. doi: 10.1093/neuonc/noz098.
Marissa Spino, Sylvia C. Kurz, Luis Chiriboga, Jonathan Serrano, Briana Zeck, Namita Sen, Seema Patel, Guomiao Shen, Varshini Vasudevaraja, Carter M. Suryadevara, Joshua Frenster, Kensuke Tateishi, Hiroaki Wakimoto, Rajan Jain, Howard A. Riina, Theodore P. Nicolaides, Erik P. Sulman, Daniel P. Cahill, John G. Golfinos, Kumiko Isse, Laura R. Saunders, David Zagzag, Dimitris G. Placantonakis, Matija Snuderl, & Andrew S. Chi. Cell surface Notch ligand DLL3 is a therapeutic target in isocitrate dehydrogenase mutant glioma. Clin Cancer Res 2019; 25(4):1261-1271. DOI:10.1158/1078-0432.CCR-18-2312.
Frank, M.O., Koyama, T., Rhrissorrakrai, K., Robine, N., Utro, F., Emde,A.-K., Chen, B.-J., Arora, K., Shah, M., Geiger, H., Felice, V., Dikoglu, E., Rahman, S., Fang, A., Vacic, V., Bergmann, E.A., Moore Vogel, J.L., Reeves, C., Khaira, D., Calabro, A., Kim, D., Lamendola-Essel, M.F., Esteves, C., Agius, P., Stolte, C., Boockvar, J., Demopoulos, A., Placantonakis, D.G., Golfinos, J.G., Brennan, C., Bruce, J., Lassman, A.B., Canoll, P., Grommes, C., Daras, M., Diamond, E., Omuro, A., Penstova, E., DeAngelis, L., Orange, D.E., Harvey,S.,Posner, J.B.,Michelini, V.V., Jobanputra, V., Zody, M.C., Kelly, J., Parida, L., Wrzeszczynski, K.O., Royyuru, A.K. & Darnell, R.B. Sequencing and curation strategies for identifying candidate glioblastoma treatments. BMC Medical Genomics 2019; 12(1):56. doi: 10.1186/s12920-019-0500-0.
Daniel P. Depledge, Srinivas Kalanghad Puthankalam, Tomohiko Sadaoka, Devin Bready, Yasuko Mori, Dimitris G. Placantonakis, Ian Mohr, and Angus C Wilson. Direct RNA sequencing on nanopore arrays redefines the transcriptional complexity of a viral pathogen. Nature Communications 2019; 10(1):754. doi: 10.1038/s41467-019-08734-9.
2018
Xin Cui, Renee-Tyler Tan Morales, Weiyi Qian, Haoyu Wang, Jean-Pierre Gagner, Igor Dolgalev, Dimitris G. Placantonakis, David Zagzag, Luisa Cimmino, Matija Snuderl, Raymond H. W. Lam, & Weiqiang Chen. Hacking Macrophage-Associated Immunosuppression for Regulating Glioblastoma Angiogenesis. Biomaterials 2018; 161:164-178. doi: 10.1016/j.biomaterials.2018.01.053.
Matija Snuderl, Kasthuri Kannan, Elke Pfaff, Shiyang Wang, James Stafford, Jonathan Serrano, Adriana Heguy, Karina Ray, Arline Faustin, Olga Aminova, Igor Dolgalev, Stacie L. Stapleton, David Zagzag, Luis Chiriboga, Sharon L. Gardner, Jeffrey H. Wisoff, John G. Golfinos, David Capper, Volker Hovestadt, Marc Rosenblum, Dimitris G. Placantonakis, Sarah LeBoeuf, Thales Papagiannakopoulos, Lukas Chavez, Sama Ahsan, Charles G. Eberhart, Stefan M. Pfister, David T. W. Jones, & Matthias A. Karajannis. Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP containing the ancestral DUF1220 domain in pineoblastoma. Nature Communications 2018; 9(1):2868. doi: 10.1038/s41467-018-05029-3.
Lucidio P. Nunes Neto, Guillaume Madelin, Terlika Pandit Sood, Chih-Chun Wu, Douglas Kondziolka, Dimitris G. Placantonakis, John G. Golfinos, Andrew Chi, Rajan Jain. Quantitative Sodium Imaging and Gliomas: A Feasibility Study. Neuroradiology 2018; 60(8):795-802. doi: 10.1007/s00234-018-2041-1.
Chih-Chin Wu, Rajan Jain, Alireza Radmanesh, Laila M. Poisson, Wan-Yuo Guo, David Zagzag, Matija Snuderl, Dimitris G. Placantonakis, John Golfinos, Andrew S. Chi. Predicting genotype and survival in glioma using standard clinical MR ADC images. Am J Neuroradiol 2018; 39(10):1814-1820. doi: 10.3174/ajnr.A5794.
James M. Stafford, Chul-Hwan Lee, Philipp Voigt, Nicolas Descostes, Ricardo Saldaña-Meyer, Jia-Ray Yu, Gary Leroy, Ozgur Oksuz, Jessica R. Chapman, Fernando Suarez, Aram S. Modrek, Nermin S. Bayin, Dimitris G. Placantonakis, Matthias A. Karajannis, Matija Snuderl, Beatrix Ueberheide, Danny Reinberg. Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma. Science Advances 2018; 4(10):eaau5935. doi: 10.1126/sciadv.aau5935.
2017
Bayin, N.S., Frenster, J.D., Sen, R., Si, S., Modrek, A. S., Galifianakis, N., Dolgalev, I., Ortenzi, V., Illa-Bochaca, I., Khahera, A., Serrano, J., Chiriboga, L., Zagzag, D., Golfinos, J.G., Doyle, W., Heguy, A., Chesler, M., Barcellos-Hoff, M.H., Snuderl, M., & Placantonakis, D. G. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget 2017; 8:64932-64953. doi:10.18632/oncotarget.18117.
Pourchet, A., Modrek, A.S., Placantonakis, D.G., Mohr, I., & Wilson, A.C. Modeling HSV-1 latency in human embryonic stem cell-derived neurons. Pathogens 2017; 6(2):24. doi:10.3390/pathogens6020024.
Frenster, J.D., Inocencio, J. F., Xu, Z., Dhaliwal, J., Alghamdi, A., Zagzag, D., Bayin, N.S., & Placantonakis, D.G. GPR133 promotes glioblastoma growth in hypoxia. Neurosurgery 2017; 64(CN_suppl_1):177-181. doi: 10.1093/neuros/nyx227.
Modrek, A. S., Golub, D., Khan, T., Bready, D., Prado, J., Bowman, C., Deng, J., Zhang, G., Rocha, P., Raviram, R., Lazaris, H., Stafford, J., LeRoy, G., Kader, M., Dhaliwal, J., Bayin, N. S., Frenster, J., Serrano, J., Chiriboga, L., Baitalmal, R., Chi, A., Golfinos, J. G., Wang, J., Karajannis, M., Bonneau, R., Reinberg, D., Tsirigos, A., Snuderl, M., Zagzag, D., Skok, J., Neubert, T., & Placantonakis, D. G. Low-grade astrocytoma mutations IDH1, P53 and ATRX cooperate to block differentiation of human neural stem cells via repression of SOX2. Cell Reports 2017; 21(5):1267-1280.
2016
Bayin, N.S., Frenster, J.D., Kane, J.R., Modrek, A.S., Shohdy, N., MacNeil, D.J., Zagzag, D., & Placantonakis, D.G. GPR133 promotes glioblastoma growth. Neurosurgery 2016; 63 Suppl 1:158-9.
Tyagi, V., Theobald, J., Barger, J., Bustoros, M., Bayin, N.S., Modrek, A.S., Anderer, E., Donahue, B., Fatterpekar, G., & Placantonakis, D.G. Traumatic Brain Injury and Subsequent Glioblastoma Development: Review of the Literature and Case Reports. Surgical Neurology International 2016; 7:78. doi: 10.4103/2152-7806.189296.
Bayin, N.S., Frenster, J.D., Kane, J.R., Rubenstein, J., Modrek, A.S., Baitalmal, R., Dolgalev, I., Rudzenski, K., Snuderl, M., Golfinos, J.G., Doyle, W., Pacione, D., Parker, E.C., Chi, A.S., Heguy, A., MacNeil, D.J., Shohdy, N., Zagzag, D., & Placantonakis, D.G. GPR133 (ADGRD1), an adhesion G protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis 2016; 5(10):e263. doi:10.1038/oncsis.2016.63.
Bayin, N.S., Ma, L., Thomas, C., Baitalmal, R., Sure, A., Fansiwala, K., Bustoros, M., Golfinos, J.G., Pacione, D., Snuderl, M., Zagzag, D., Barcellos-Hoff, M.H., & Placantonakis, D.G. Patient-specific screening using high-grade glioma explants to determine potential radiosensitization by a TGF-β small molecule inhibitor. Neoplasia 2016; 18:795-805.
2015
Basu-Roy, U., Bayin, N. S., Rattanakorn, K., Han, E., Placantonakis, D. G., Mansukhani, A., & Basilico, C. SOX2 Antagonizes the Hippo Pathway to Maintain Stemness in Cancer Cells. Nature Communications 2015; 6:6411.
2014
Bayin, N. S., Modrek, A., Dietrich, A., Abel, T., Song, H.-R., Schober, M., Buchholz, C., Chao, M., & Placantonakis, D. G. Selective Lentiviral Gene Delivery into CD133-expressing human Glioblastoma Stem Cells. PLoSOne 2014; 9:e116114.
Bayin, N. S., & Placantonakis, D. G. Heterogeneity and Diversity of Cancer Stem Cells in Glioblastoma. International Journal of Stem Cell Research and Therapy 2014; 1:001e.
Bayin, N.S., Modrek, A. S. & Placantonakis, D. G. Glioblastoma Stem Cells: Molecular Characteristics and Therapeutic Implications. World Journal of Stem Cells 2014; 6:230-238.
Modrek, A. S., Bayin, N.S. & Placantonakis, D. G. Stem cells as the cell of origin in glioma. World Journal of Stem Cells 2014; 6:43-52.
INVITED ARTICLES
2019
D. Bready & D. G. Placantonakis. Molecular pathogenesis of low-grade glioma. Neurosurgery Clinics of North America 2019; 30(1):17-25. doi: 10.1016/j.nec.2018.08.01.
2018
J. Frenster & D. G. Placantonakis. Establishing primary human glioblastoma tumorsphere cultures from operative specimens. Methods in Molecular Biology 2018; 1741:63-69.
J. Inocencio, J. Frenster, & D. G. Placantonakis. Isolation of glioblastoma stem cells with flow cytometry. Methods in Molecular Biology 2018; 1741:71-79.
J. Frenster, J. Inocencio, & D. G. Placantonakis. Lentiviral transduction of primary human glioblastoma cultures. Methods in Molecular Biology 2018; 1741:81-89.
N.S. Bayin, & D. G. Placantonakis. Selective targeting of CD133-expressing glioblastoma stem cells using lentiviral vectors. Methods in Molecular Biology 2018; 1741:91-101.
N. Galifianakis, D.G. Placantonakis, & M. Chesler. Intracellular pH measurements in glioblastoma cells using the pH-sensitive dye BCECF. Methods in Molecular Biology 2018; 1741:103-109.
R. Sen, I. Dolgalev, N.S. Bayin, Adriana Heguy, A. Tsirigos, D. G. Placantonakis. Single-Cell RNA Sequencing of glioblastoma cells. Methods in Molecular Biology 2018; 1741:151-170.
N. S. Bayin. L. Ma, D.G. Placantonakis, & M.H. Barcellos-Hoff. Evaluation of radioresponse and radiosensitizers in glioblastoma organotypic cultures. Methods in Molecular Biology 2018; 1741:171-182.
Z. Xu, M. Kader, R. Sen, & D. G. Placantonakis. Orthotopic patient-derived glioblastoma xenografts in mice. Methods in Molecular Biology 2018; 1741:183-190.
J. Frenster & D. G. Placantonakis. Bioluminescent in vivo imaging of orthotopic glioblastoma xenografts in mice. Methods in Molecular Biology 2018; 1741:191-198.
N.S. Bayin, & D. G. Placantonakis. Evaluation of vascularity, blood perfusion and oxygen tension in tumor xenografts with fluorescent microscopy. Methods in Molecular Biology 2018; 1741:199-207.
S. Modrek, J. Prado, D. Bready, J. Dhaliwal, D. Golub, and & D. G. Placantonakis. Modeling glioma with human embryonic stem cell-derived neural lineages. Methods in Molecular Biology 2018; 1741:227-237.